CoChat

Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trial

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

BACKGROUND Body composition is emerging as a prognostic biomarker in cancer and may be associated with treatment tolerance, side-effects, and health-related quality of life (HRQoL). It can be measured from imaging routinely acquired during patient care. We evaluated whether body composition metrics were associated with radiotherapy-related side-effects and HRQoL in patients with prostate or lung cancer using a prospective multicentre dataset. METHODS Radiotherapy planning computed tomography (CT) scans, patient and disease characteristics, and clinician- and patient-reported side-effects up to 24 months post-treatment were obtained from the REQUITE study. Skeletal muscle and intramuscular adipose tissue were segmented at the L3 and T12 vertebrae for prostate and lung patients respectively using in-house software. Standardised total average toxicity scores captured composite acute and late clinician- and patient-reported side-effects and HRQoL. Gradient boosted machine models were developed for all endpoints with and without body composition variables. Predictor importance rankings and model performance (root mean squared error (RMSE)) were assessed. RESULTS 279 lung and 848 prostate patients were available for analysis. Body composition variables were ranked in the top five most important variables for 9 of 12 endpoints. Body composition variables were ranked higher than body mass index for 9 of 12 endpoints. Adding body composition variables was associated with statistically significant (p < 0.01) but small reductions in apparent/in-sample RMSE across endpoints. CONCLUSIONS Body composition variables were frequently ranked among important predictors of radiotherapy-related side-effects and HRQoL, but their incremental improvement in apparent model fit was small. These findings suggest that CT-derived body composition may warrant further investigation as an exploratory imaging biomarker, but external validation and demonstration of clinically meaningful incremental value are required before clinical implementation.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2026.111673

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 37 references

Cited by

Still being checked.

Metadata

Authors
Vickers, A. J., McSweeney, D. M., Choudhury, A., Weaver, J., West, C., Kerns, S., Azria, D., Farcy-Jaquet, M.-P., Chang-Claude, J., Dunning, A., Lambrecht, M., Avuzzi, B., De Ruysscher, D., Seibold, P., Sperk, E., Talbot, C., Vega, A., Veldeman, L., Bultijnck, R., Webb, A., Rosenstein, B., Rancati, T., Gioscio, E., Price, G., & McWilliam, A.
Affiliations
  • University of Manchester (GB)
  • Medical College of Wisconsin (US)
  • Inserm (FR)
  • Universität Hamburg (DE)
  • University of Cambridge (GB)
  • KU Leuven (BE)
  • Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
  • German Cancer Research Center (DE)
  • Heidelberg University (DE)
  • Centre for Biomedical Network Research on Rare Diseases (ES)
  • Ghent University Hospital (BE)
  • University of Leicester (GB)
  • Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Vickers, Alexander J.
Venue
Radiotherapy and Oncology
Publisher
Elsevier BV
Published
2026-09
Volume
222
Pages
111673
ISSN
0167-8140 (ISSN-L)
OpenAlex
W7166353596
Cited by
0
References
37
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Locations
  • Radiotherapy and Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion)
Funders
  • NIHR Manchester Biomedical Research Centre (NIHR203308)
  • Cancer Research UK (RRCOER-Jun24/100008, CTRQQR-2021\\100010, C1994/A28701)
  • NIHR Imperial Biomedical Research Centre
  • Cancer Research UK Manchester Centre
  • National Institute for Health and Care Research
Topics
  • Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
Keywords
body composition, radiotherapy complications, health-related quality of life, prostate cancer, lung cancer, skeletal muscle, intramuscular fat, CT-derived body composition, imaging biomarkers, prognostic factors, toxicity prediction
MeSH terms
Aged, Body Composition, Humans, Lung Neoplasms, Male, Middle Aged, Prospective Studies, Prostatic Neoplasms, Quality of Life, Tomography, X-Ray Computed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trial. https://app.cochat.ai/papers/10.1016/j.radonc.2026.111673
The paper
Vickers, A. J., McSweeney, D. M., Choudhury, A., Weaver, J., West, C., Kerns, S., Azria, D., Farcy-Jaquet, M.-P., Chang-Claude, J., Dunning, A., Lambrecht, M., Avuzzi, B., De Ruysscher, D., Seibold, P., Sperk, E., Talbot, C., Vega, A., Veldeman, L., Bultijnck, R., . . . McWilliam, A. (2026). Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trial. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2026.111673

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.